Yorktown Management & Research CO Inc Genmab A/S Transaction History

Yorktown Management & Research CO Inc

  • $93.2 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023
BUY
$33.8 - $47.06 $219,699 - $305,890
6,500 Added 64.36%
16,600 $0
Q1 2021

May 11, 2021
BUY
$30.92 - $44.4 $139,140 - $199,800
4,500 Added 80.36%
10,100 $332,000
Q4 2020

Feb 11, 2021
BUY
$33.66 - $40.76 $188,495 - $228,256
5,600 New
5,600 $228,000

Others Institutions Holding GMAB

# of Institutions
236
Shares Held
52.5M
Call Options Held
10.2K
Put Options Held
25.5K
View Full List

About GENMAB A/S

GMAB Quotes by TradingView
  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.6B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Yorktown Management & Research CO Inc Portfolio

Follow Yorktown Management & Research CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yorktown Management & Research CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Yorktown Management & Research CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email